Palisade Bio, Inc. (PALI)
2.01
-0.04
(-1.95%)
USD |
NASDAQ |
Sep 10, 16:00
2.05
+0.04
(+1.99%)
After-Hours: 20:00
Palisade Bio Market Cap : 348.93M for Sept. 10, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 10, 2026 | 348.93M |
| September 09, 2026 | 355.87M |
| September 08, 2026 | 381.91M |
| September 04, 2026 | 362.81M |
| September 03, 2026 | 355.00M |
| September 02, 2026 | 345.45M |
| September 01, 2026 | 340.25M |
| August 31, 2026 | 338.51M |
| August 28, 2026 | 347.19M |
| August 27, 2026 | 366.29M |
| August 26, 2026 | 369.76M |
| August 25, 2026 | 359.34M |
| August 24, 2026 | 348.93M |
| August 21, 2026 | 364.55M |
| August 20, 2026 | 357.61M |
| August 19, 2026 | 374.97M |
| August 18, 2026 | 354.13M |
| August 17, 2026 | 373.23M |
| August 14, 2026 | 371.49M |
| August 13, 2026 | 373.23M |
| August 12, 2026 | 340.25M |
| August 11, 2026 | 371.49M |
| August 10, 2026 | 364.55M |
| August 07, 2026 | 366.29M |
| August 06, 2026 | 362.81M |
| Date | Value |
|---|---|
| August 05, 2026 | 354.93M |
| August 04, 2026 | 346.56M |
| August 03, 2026 | 324.80M |
| July 31, 2026 | 317.26M |
| July 30, 2026 | 328.15M |
| July 29, 2026 | 328.15M |
| July 28, 2026 | 338.19M |
| July 27, 2026 | 339.87M |
| July 24, 2026 | 326.47M |
| July 23, 2026 | 338.19M |
| July 22, 2026 | 318.10M |
| July 21, 2026 | 321.45M |
| July 20, 2026 | 319.78M |
| July 17, 2026 | 329.82M |
| July 16, 2026 | 316.43M |
| July 15, 2026 | 339.87M |
| July 14, 2026 | 323.12M |
| July 13, 2026 | 316.43M |
| July 10, 2026 | 328.15M |
| July 09, 2026 | 329.82M |
| July 08, 2026 | 343.21M |
| July 07, 2026 | 348.24M |
| July 06, 2026 | 341.54M |
| July 02, 2026 | 351.59M |
| July 01, 2026 | 329.82M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 4.775B |
| Alnylam Pharmaceuticals, Inc. | 33.10B |
| Anika Therapeutics, Inc. | 280.91M |
| Savara, Inc. | 1.093B |
| Vericel Corp. | 1.938B |
Market Cap Related Metrics
| PS Ratio | 590.90 |
| Price to Book Value | 2.866 |
| Price | 2.01 |
| Earnings Yield | -26.63% |